BUY Himadri Speciality Chemical Limited — Ajit Mishra, Religare
byAjit Mishra, ReligareHorizon: NA (inferred Swing (≤2wk))17 Jul 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Himadri Speciality Chemical shares hit fresh 52-week high, up for 9th consecutive day after Q1 results
NewsLivemint·21 Jul · 1w ago
Himadri Speciality Chemical Limited reported record quarterly Revenue, EBITDA, and PAT for the quarter ended June 30, 2026. Revenue was Rs. 1,432 Cr, EBITDA Rs. 313 Cr (22% margin), and PAT Rs. 228 Cr
NSE · Press Release·15 Jul · 2w ago
Himadri Speciality Chemical Ltd reported record quarterly Revenue, EBITDA, and PAT for the quarter ended June 30, 2026. Revenue was Rs. 1,432 Cr (+28% YoY), EBITDA was Rs. 313 Cr (+33% YoY), and PAT w
BSE · Company Update·15 Jul · 2w ago
ICRA has upgraded Himadri Speciality Chemical Ltd's long-term rating to [ICRA]AA- (Stable) from [ICRA]AA- (Positive) and reaffirmed the short-term rating at [ICRA]A1+. The outlook has been revised to
BSE · Company Update·10 Jul · 3w ago
Buy, Sell Or Hold: Godrej Consumer, Genus Power, Himadri Speciality Chemical, NTPC Green, MRPL — Ask Profit
NewsNdtv-Profit·23 Jul · 1w ago
Himadri Speciality Chemical Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·15 Jul · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Himadri Speciality Chemical
- BUY — Dr. Ravi Singh, Dr Ravi Prakash Singh Proprietor DRSFINVEST14 Oct 2026 · ~3 months · target ₹819.5 · Active
- BUY — Rachna Vaidya27 Aug 2026 · Same day · target ₹680 · Expired
- BUY — IDBI Capital14 Aug 2026 · ~3 months · target ₹848 · SL hit
- BUY — Rupak De, LKP Securities13 Aug 2026 · ~2 weeks · target ₹840 · SL hit
- BUY — Prakash Gaba13 Aug 2026 · Same day · target ₹800 · Expired
More from Ajit Mishra, Religare
- BUY Dr. Reddy's Laboratories19 Oct 2026 · ~2 weeks · target ₹1,310 · Active
- BUY The Indian Hotels Company19 Oct 2026 · ~2 weeks · target ₹850 · SL hit
- BUY Kotak Mahindra Bank16 Oct 2026 · ~2 weeks · target ₹471 · SL hit
- BUY The Indian Hotels Company16 Oct 2026 · ~2 weeks · target ₹790 · Active
- BUY Kotak Mahindra Bank16 Oct 2026 · ~2 weeks · target ₹470 · SL hit

